{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T22:41:52Z","timestamp":1783204912466,"version":"3.54.6"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["SR\/FST\/2022\/252"],"award-info":[{"award-number":["SR\/FST\/2022\/252"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.bioorg.2023.106971","type":"journal-article","created":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T13:50:53Z","timestamp":1700661053000},"page":"106971","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Synthetic and pharmacological developments in the hybrid s-triazine moiety: A review"],"prefix":"10.1016","volume":"143","author":[{"given":"Diksha","family":"Bareth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonika","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti","family":"Kumawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dharma","family":"Kishore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaya","family":"Dwivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2761-4614","authenticated-orcid":false,"given":"Sonia Zeba","family":"Hashmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bioorg.2023.106971_b0005","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3390\/molecules26040864","article-title":"s-Triazine: A privileged structure for drug discovery and bioconjugation","volume":"26","author":"Sharma","year":"2021","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.bioorg.2023.106971_b0010","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.3762\/bjoc.16.142","article-title":"Microwave-assisted efficient one-pot synthesis of N2-(tetrazol-5-yl)-6-aryl\/heteroaryl-5, 6-dihydro-1, 3, 5-triazine-2, 4-diamines","volume":"16","author":"Moustafa","year":"2020","journal-title":"Beilstein J. Org. Chem."},{"key":"10.1016\/j.bioorg.2023.106971_b0015","doi-asserted-by":"crossref","unstructured":"Shahari, M. S. B., &Dolzhenko, A. V. (2022). A closer look at N2, 6-substituted 1, 3, 5-triazine-2, 4-diamines: Advances in synthesis and biological activities.Eur. J. Med. Chem.,241, 114645. https:\/\/doi.org\/10.1016\/j.ejmech.2022.114645.","DOI":"10.1016\/j.ejmech.2022.114645"},{"issue":"9","key":"10.1016\/j.bioorg.2023.106971_b0020","doi-asserted-by":"crossref","DOI":"10.1134\/S1070363222090055","article-title":"Synthesis and In vitro Study of Cytotoxic Activity of New Tetrazole-Containing 2, 4-Diamino-1, 3, 5-triazine Derivatives","volume":"92","author":"Mikolaichuk","year":"2022","journal-title":"Russ. J. Gen. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2023.106971_b0025","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3390\/inorganics11050222","article-title":"Synthesis, X-ray Structure of Two Hexa-Coordinated Ni (II) Complexes with s-Triazine Hydrazine Schiff Base Ligand","volume":"11","author":"Fathalla","year":"2023","journal-title":"Inorganics"},{"issue":"2","key":"10.1016\/j.bioorg.2023.106971_b0030","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1039\/D2RE00389A","article-title":"Synthesis, combined theoretical and spectral characterization of some new 1, 3, 5 triazine compounds, and their in vitro biological analysis","volume":"8","author":"Noureen","year":"2023","journal-title":"React. Chem. Eng."},{"key":"10.1016\/j.bioorg.2023.106971_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.tet.2023.133293","article-title":"Design, synthesis and anti-cancer evaluation of genistein-1, 3, 5-triazine derivatives","volume":"134","author":"Zou","year":"2023","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bioorg.2023.106971_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2023.105586","article-title":"Synthesis of deuterated S-217622 (Ensitrelvir) with antiviral activity against coronaviruses including SARS-CoV-2","volume":"213","author":"Yang","year":"2023","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bioorg.2023.106971_b0045","doi-asserted-by":"crossref","unstructured":"Verma, T., Sinha, M., & Bansal, N. (2020). Heterocyclic compounds bearing triazine scaffold and their biological significance: A review.Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents),20(1), 4-28. https:\/\/doi.org\/10.2174\/1871520619666191028111351.","DOI":"10.2174\/1871520619666191028111351"},{"key":"10.1016\/j.bioorg.2023.106971_b0050","doi-asserted-by":"crossref","unstructured":"A. Pinner, Berichte d. D. chem. Gesellsohaft. Jahrg, 1890, XXIII, 2919\u20132922.","DOI":"10.1002\/cber.189002302208"},{"key":"10.1016\/j.bioorg.2023.106971_b0055","doi-asserted-by":"crossref","unstructured":"Demuth, R., & Meyer, V. (1890). VerfahrenzurBestimmung der Dampfdichte von K\u00f6rpernunterhalbihrerSiedetemperaturBerichte der deutschenchemischen Gesellschaft,23(1), 311-316. https:\/\/doi.org\/10.1021\/jo01107a001.","DOI":"10.1002\/cber.18900230152"},{"issue":"1","key":"10.1016\/j.bioorg.2023.106971_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/jo01107a001","article-title":"Chemical and Biological Studies on 1, 2-Dihydro-s-triazines. II. Three-Component Synthesis1","volume":"21","author":"Modest","year":"1956","journal-title":"J. Org. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2023.106971_b0065","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1021\/jo01058a033","article-title":"The Preparation of s-Triazine Derivatives Containing the N\u2014O Bond. I. Mono-N-oxides of Amino-substituted s-Triazine Derivatives1","volume":"27","author":"Shaw","year":"1962","journal-title":"J. Org. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2023.106971_b0070","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1039\/B202014A","article-title":"Synthesis of 1, 3, 5-triazines in solvent-free conditions catalysed by silica-supported lewis acids","volume":"4","author":"D\u00edaz-Ortiz","year":"2002","journal-title":"Green Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2023.106971_b0075","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1039\/B315956F","article-title":"Green synthesis and self-association of 2, 4-diamino-1, 3, 5-triazine derivatives","volume":"28","author":"D\u00edaz-Ortiz","year":"2004","journal-title":"New J. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2023.106971_b0080","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1021\/cc049950x","article-title":"Microwave-assisted parallel synthesis of a 4, 6-diamino-2, 2-dimethyl-1, 2-dihydro-1-phenyl-s-triazine library","volume":"6","author":"Lee","year":"2004","journal-title":"J. Comb. Chem."},{"key":"10.1016\/j.bioorg.2023.106971_b0085","doi-asserted-by":"crossref","unstructured":"Huang, H., Guo, W., Wu, W., Li, C. J., & Jiang, H. (2015). Copper-catalyzed oxidative C (sp3)\u2013H functionalization for facile synthesis of 1, 2, 4-triazoles and 1, 3, 5-triazines from amidines.Organic letters,17(12), 2894-2897.https:\/\/doi.org\/10.1021\/acs.orglett.5b00995.","DOI":"10.1021\/acs.orglett.5b00995"},{"issue":"42","key":"10.1016\/j.bioorg.2023.106971_b0090","doi-asserted-by":"crossref","first-page":"10511","DOI":"10.1016\/j.tet.2007.07.079","article-title":"From dicarbonylallene to 1-aryl-3, 6-dimethyl-4-aminoaryl-2-pyridones: a one-pot versatile and uncatalyzed synthesis","volume":"63","author":"Boisse","year":"2007","journal-title":"Tetrahedron"},{"issue":"3","key":"10.1016\/j.bioorg.2023.106971_b0095","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.tetlet.2006.11.069","article-title":"A novel one-pot synthesis of N, 6-disubstituted 1, 3, 5-triazine-4, 6-diamines from isothiocyanates and amidines","volume":"48","author":"Liu","year":"2007","journal-title":"Tetrahedron Lett."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106971_b0100","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/157017807780037469","article-title":"Multicomponent solvent-free cyclocondensation\/glycosylation strategy for thiazolo-s-triazine N-nucleosides","volume":"4","author":"Yadav","year":"2007","journal-title":"Lett. Org. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2023.106971_b0105","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1021\/jo0625352","article-title":"Microwave-assisted one-pot tandem reactions for direct conversion of primary alcohols and aldehydes to triazines and tetrazoles in aqueous media","volume":"72","author":"Shie","year":"2007","journal-title":"J. Org. Chem."},{"issue":"24","key":"10.1016\/j.bioorg.2023.106971_b0110","doi-asserted-by":"crossref","first-page":"6723","DOI":"10.1039\/C5OB00724K","article-title":"Synthesis of 1, 3, 5-triazines via Cu (OAc) 2-catalyzed aerobic oxidative coupling of alcohols and amidine hydrochlorides","volume":"13","author":"You","year":"2015","journal-title":"Org. Biomol. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106971_b0115","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1039\/C5GC01884F","article-title":"Polythene glycol (PEG) as a reusable solvent system for the synthesis of 1, 3, 5-triazines via aerobic oxidative tandem cyclization of benzylamines and N-substituted benzylamines with amidines under transition metal-free conditions","volume":"18","author":"Tiwari","year":"2016","journal-title":"Green Chem."},{"issue":"41","key":"10.1016\/j.bioorg.2023.106971_b0120","doi-asserted-by":"crossref","first-page":"10285","DOI":"10.1039\/C5OB01799H","article-title":"Direct oxidative coupling of amidine hydrochlorides and methylarenes: TBHP-mediated synthesis of substituted 1, 3, 5-triazines under metal-free conditions","volume":"13","author":"Guo","year":"2015","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bioorg.2023.106971_b0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2013.03.063","article-title":"Synthesis of pyrazolo [1, 5-a][1, 3, 5] triazine derivatives as inhibitors of thymidine phosphorylase","volume":"65","author":"Sun","year":"2013","journal-title":"Eur. J. Med. Chem."},{"issue":"15","key":"10.1016\/j.bioorg.2023.106971_b0130","doi-asserted-by":"crossref","first-page":"7012","DOI":"10.1021\/jo501144v","article-title":"One-pot synthesis of 1, 3, 5-triazine derivatives via controlled cross-cyclotrimerization of nitriles: A mechanism approach","volume":"79","author":"Herrera","year":"2014","journal-title":"J. Org. Chem."},{"issue":"13","key":"10.1016\/j.bioorg.2023.106971_b0135","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1021\/ol501493h","article-title":"A novel straightforward synthesis of 2, 4-disubstituted-1, 3, 5-triazines via aerobic copper-catalyzed cyclization of amidines with DMF","volume":"16","author":"Xu","year":"2014","journal-title":"Org. Lett."},{"issue":"17","key":"10.1016\/j.bioorg.2023.106971_b0140","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1039\/C3OB42589D","article-title":"An efficient ruthenium-catalyzed dehydrogenative synthesis of 2, 4, 6-triaryl-1, 3, 5-triazines from aryl methanols and amidines","volume":"12","author":"Xie","year":"2014","journal-title":"Org. Biomol. Chem."},{"issue":"10","key":"10.1016\/j.bioorg.2023.106971_b0145","doi-asserted-by":"crossref","first-page":"8225","DOI":"10.1039\/C6NJ01620K","article-title":"Ruthenium-catalyzed synthesis of tri-substituted 1, 3, 5-triazines from alcohols and biguanides","volume":"40","author":"Zeng","year":"2016","journal-title":"New J. Chem."},{"key":"10.1016\/j.bioorg.2023.106971_b0150","first-page":"326","article-title":"Design, synthesis and characterization of [1, 3, 4] thiadiazolo-and [1, 2, 4] oxadiazolo-substituted 2, 4-dicyclopropylamino-6-phenoxy-s-triazines","volume":"318","author":"Hashmi","year":"2016","journal-title":"ARKIVOC"},{"issue":"5","key":"10.1016\/j.bioorg.2023.106971_b0155","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1002\/jhet.2901","article-title":"Novel Synthesis of Imidazo-based and Benzimidazo-based privileged Templates on s-Triazine Nucleus through a Phenoxyl Spacer","volume":"54","author":"Zeba Hashmi","year":"2017","journal-title":"J. Heterocycl. Chem."},{"issue":"16","key":"10.1016\/j.bioorg.2023.106971_b0160","doi-asserted-by":"crossref","first-page":"9522","DOI":"10.1021\/acs.joc.8b01249","article-title":"Synthesis of Azolo [1, 3, 5] triazines via Rhodium (III)-Catalyzed Annulation of N-Azolo Imines and Dioxazolones","volume":"83","author":"Hoang","year":"2018","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2023.106971_b0165","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.catcom.2019.05.005","article-title":"Base-free synthesis of 1, 3, 5-triazines via aerobic oxidation of alcohols and benzamidine over a recyclable OMS-2 catalyst","volume":"127","author":"Shen","year":"2019","journal-title":"Catal. Commun."},{"issue":"7","key":"10.1016\/j.bioorg.2023.106971_b0170","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1021\/acscombsci.9b00079","article-title":"New One-Pot Synthesis of 1, 3, 5-Triazines: Three-Component Condensation, Dimroth Rearrangement, and Dehydrogenative Aromatization","volume":"21","author":"Junaid","year":"2019","journal-title":"ACS Comb. Sci."},{"key":"10.1016\/j.bioorg.2023.106971_b0175","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ejmech.2019.04.055","article-title":"Structure-guided optimization of 4, 6-substituted-1, 3, 5-triazin-2 (1H)-ones as catalytic inhibitors of human DNA topoisomerase II\u03b1","volume":"175","author":"Bergant","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106971_b0180","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.3762\/bjoc.16.120","article-title":"One-pot synthesis of 1, 3, 5-triazine-2, 4-dithione derivatives via three-component reactions","volume":"16","author":"Kang","year":"2020","journal-title":"Beilstein J. Org. Chem."},{"key":"10.1016\/j.bioorg.2023.106971_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.134922","article-title":"Synthesis, characterization, and DFT study of the s-triazine analogues of medicinal interest incorporated with five-and six-membered bioactive heterocyclic scaffolds","volume":"1278","author":"Hashmi","year":"2023","journal-title":"J. Mol. Struct."},{"issue":"19","key":"10.1016\/j.bioorg.2023.106971_b0190","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1016\/j.bmcl.2009.08.052","article-title":"Synthesis and in vitro evaluation of 2, 4-diamino-v,3,5-triazine derivatives as neuronal voltage-gated sodium channel blockers","volume":"19","author":"Ma","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"9","key":"10.1016\/j.bioorg.2023.106971_b0195","doi-asserted-by":"crossref","first-page":"15976","DOI":"10.3390\/molecules200915976","article-title":"Synthesis and preliminary biological evaluation of 1, 3, 5-triazine amino acid derivatives to study their MAO inhibitors","volume":"20","author":"Khattab","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2023.106971_b0200","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1016\/j.bmcl.2017.06.007","volume":"27","author":"Wei","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2023.106971_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112339","article-title":"Discovery of potent and highly selective covalent inhibitors of Bruton\u2019s tyrosine kinase bearing triazine scaffold","volume":"199","author":"Teng","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106971_b0210","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ejmech.2016.11.019","article-title":"An insight on synthetic and medicinal aspects of pyrazolo [1, 5-a] pyrimidine scaffold","volume":"126","author":"Cherukupalli","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106971_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.133615","article-title":"New s-Triazine\/Tetrazole conjugates as potent antifungal and antibacterial agents: Design, molecular docking and mechanistic study","volume":"1267","author":"Mekheimer","year":"2022","journal-title":"J. Mol. Struct."},{"issue":"11","key":"10.1016\/j.bioorg.2023.106971_b0220","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1021\/acschembio.6b00510","article-title":"Discovery of allosteric and selective inhibitors of inorganic pyrophosphatase from Mycobacterium tuberculosis","volume":"11","author":"Pang","year":"2016","journal-title":"ACS Chem. Biol."},{"issue":"11","key":"10.1016\/j.bioorg.2023.106971_b0225","doi-asserted-by":"crossref","first-page":"8806","DOI":"10.1039\/C5RA10388F","article-title":"Synthesis and antimicrobial activity of triazine dendrimers with DABCO groups","volume":"6","author":"Sreeperumbuduru","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2023.106971_b0230","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ejmech.2017.12.089","article-title":"Amino acid conjugated antimicrobial drugs: Synthesis, lipophilicity-activity relationship, antibacterial and urease inhibition activity","volume":"145","author":"Ullah","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106971_b0235","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.molstruc.2017.11.087","article-title":"Synthesis, spectroscopic characterization, antimicrobial evaluation and molecular docking study of novel triazine-quinazolinone based hybrids","volume":"1156","author":"Dinari","year":"2018","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2023.106971_b0240","first-page":"8","article-title":"Synthesis and biological evaluation of novel s-triazine based aryl\/heteroaryl entities: Design, rationale and comparative study","volume":"20","author":"Mewada","year":"2016","journal-title":"J. Assoc. Arab Univ. Basic Appl. Sci."},{"key":"10.1016\/j.bioorg.2023.106971_b0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13065-017-0267-3","volume":"11","author":"Al-Zaydi","year":"2017","journal-title":"Chem. Cent. J."},{"key":"10.1016\/j.bioorg.2023.106971_b0250","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.molstruc.2017.05.040","article-title":"Novel pyrazolyl-s-triazine derivatives, molecular structure and antimicrobial activity","volume":"1145","author":"Sharma","year":"2017","journal-title":"J. Mol. Struct."},{"issue":"9","key":"10.1016\/j.bioorg.2023.106971_b0255","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.bmcl.2018.03.037","article-title":"Synthesis and evaluation of the antibacterial activities of aryl substituted dihydrotriazine derivatives","volume":"28","author":"Zhang","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"13","key":"10.1016\/j.bioorg.2023.106971_b0260","doi-asserted-by":"crossref","first-page":"10676","DOI":"10.1039\/C8NJ01483C","article-title":"Synthesis and characterization of novel dimeric s-triazine derivatives as potential anti-bacterial agents against MDR clinical isolates","volume":"42","author":"Ramadan","year":"2018","journal-title":"New J. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106971_b0265","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1038\/s41598-018-37785-z","article-title":"Cationic amphipathic triazines with potent anti-bacterial, anti-inflammatory and anti-atopic dermatitis properties","volume":"9","author":"Gunasekaran","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2023.106971_b0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103013","article-title":"Design, synthesis and molecular modeling studies of new series of s-triazine derivatives as antimicrobial agents against multi-drug resistant clinical isolates","volume":"89","author":"Haiba","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2023.106971_b0275","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ejmech.2019.01.062","article-title":"Design, synthesis and anti-bacterial studies of piperazine derivatives against drug resistant bacteria","volume":"166","author":"Tahir","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2023.106971_b0280","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.3390\/sym13071247","article-title":"A Novel centrosymmetric Fe (III) complex with anionic bis-pyrazolyl-s-triazine ligand; synthesis, structural investigations and antimicrobial evaluations","volume":"13","author":"Soliman","year":"2021","journal-title":"Symmetry"},{"issue":"9","key":"10.1016\/j.bioorg.2023.106971_b0285","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.3390\/ph16091248","article-title":"s-Triazine Derivatives Functionalized with Alkylating 2-Chloroethylamine Fragments as Promising Antimicrobial Agents: Inhibition of Bacterial DNA Gyrases, Molecular Docking Studies, and Antibacterial and Antifungal Activity","volume":"16","author":"Maliszewski","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"4","key":"10.1016\/j.bioorg.2023.106971_b0290","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.bmcl.2016.12.038","article-title":"Functionalized triazines as potent HCV entry inhibitors","volume":"27","author":"Mull","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"11","key":"10.1016\/j.bioorg.2023.106971_b0295","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1016\/j.bmc.2016.04.018","article-title":"Design, discovery, modelling, synthesis, and biological evaluation of novel and small, low toxicity s-triazine derivatives as HIV-1 non-nucleoside reverse transcriptase inhibitors","volume":"24","author":"Viira","year":"2016","journal-title":"Bioorg. Med. Chem."},{"issue":"17","key":"10.1016\/j.bioorg.2023.106971_b0300","doi-asserted-by":"crossref","first-page":"4637","DOI":"10.1016\/j.bmc.2017.06.046","article-title":"New prodrugs of two pyrimidine acyclic nucleoside phosphonates: Synthesis and antiviral activity","volume":"25","author":"Kre\u010dmerov\u00e1","year":"2017","journal-title":"Bioorg. Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2023.106971_b0305","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1248\/cpb.c18-00274","article-title":"Preparation and antiviral activity of some new C3-and CS-symmetrical tri-substituted triazine derivatives having benzylamine substituents","volume":"66","author":"Mibu","year":"2018","journal-title":"Chem. Pharm. Bull."},{"issue":"24","key":"10.1016\/j.bioorg.2023.106971_b0310","doi-asserted-by":"crossref","first-page":"8829","DOI":"10.3390\/molecules27248829","article-title":"Privileged Scaffold Decoration for the Identification of the First Trisubstituted Triazine with Anti-SARS-CoV-2 Activity","volume":"27","author":"Cesarini","year":"2022","journal-title":"Molecules"},{"issue":"11","key":"10.1016\/j.bioorg.2023.106971_b0315","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1080\/07391102.2019.1654924","article-title":"Synthesis, characterization, and anticancer activity of Schiff bases","volume":"38","author":"Uddin","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106971_b0320","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ctrv.2007.08.001","article-title":"Novel cytotoxic drugs: old challenges, new solutions","volume":"34","author":"Ismael","year":"2008","journal-title":"Cancer Treat. Rev."},{"issue":"7782","key":"10.1016\/j.bioorg.2023.106971_b0325","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","article-title":"A view on drug resistance in cancer","volume":"575","author":"Vasan","year":"2019","journal-title":"Nature"},{"issue":"15","key":"10.1016\/j.bioorg.2023.106971_b0330","doi-asserted-by":"crossref","first-page":"7268","DOI":"10.1021\/acs.jmedchem.6b00235","article-title":"Design, synthesis, and biological evaluation of substituted pyrimidines as potential phosphatidylinositol 3-kinase (PI3K) inhibitors","volume":"59","author":"Zhang","year":"2016","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2023.106971_b0335","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.bmcl.2015.11.083","article-title":"Synthesis, in vitro antitumor activity, dihydrofolate reductase inhibition, DNA intercalation and structure\u2013activity relationship studies of 1, 3, 5-triazine analogues","volume":"26","author":"Singla","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"6","key":"10.1016\/j.bioorg.2023.106971_b0340","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1021\/acs.jmedchem.5b01655","article-title":"Discovery of bifunctional oncogenic target inhibitors against allosteric mitogen-activated protein kinase (MEK1) and phosphatidylinositol 3-kinase (PI3K)","volume":"59","author":"Van Dort","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106971_b0345","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ejmech.2016.06.010","article-title":"Discovery and antiplatelet activity of a selective PI3K\u03b2 inhibitor (MIPS-9922)","volume":"122","author":"Zheng","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106971_b0350","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejmech.2016.03.088","article-title":"Synthesis and in vitro evaluation of novel triazine analogues as anticancer agents and their interaction studies with bovine serum albumin","volume":"117","author":"Singla","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106971_b0355","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.ejmech.2018.06.052","article-title":"Targeting prohibitin with small molecules to promote melanogenesis and apoptosis in melanoma cells","volume":"155","author":"Djehal","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2023.106971_b0360","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1016\/j.bmcl.2016.02.085","article-title":"Synthesis and in vitro anticancer evaluation of some 4, 6-diamino-1, 3, 5-triazine-2-carbohydrazides as Rad6 ubiquitin conjugating enzyme inhibitors","volume":"26","author":"Kothayer","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"19","key":"10.1016\/j.bioorg.2023.106971_b0365","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1016\/j.bmcl.2016.08.028","article-title":"Development of single and mixed isoform selectivity PI3K\u03b4 inhibitors by targeting Asn836 of PI3K\u03b4","volume":"26","author":"Miller","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"23","key":"10.1016\/j.bioorg.2023.106971_b0370","doi-asserted-by":"crossref","first-page":"10629","DOI":"10.1021\/acs.jmedchem.6b01342","article-title":"Substituent effects on drug\u2013receptor H-bond interactions: correlations useful for the design of kinase inhibitors","volume":"59","author":"Lawhorn","year":"2016","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2023.106971_b0375","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1021\/acs.jmedchem.8b00125","article-title":"4, 6-Diaminopyrimidines as highly preferred troponin I-interacting kinase (TNNI3K) inhibitors","volume":"61","author":"Philp","year":"2018","journal-title":"J. Med. Chem."},{"issue":"17","key":"10.1016\/j.bioorg.2023.106971_b0380","doi-asserted-by":"crossref","first-page":"7524","DOI":"10.1021\/acs.jmedchem.7b00930","article-title":"5-(4, 6-Dimorpholino-1, 3, 5-triazin-2-yl)-4-(trifluoromethyl) pyridin-2-amine (PQR309), a potent, brain-penetrant, orally bioavailable, pan-class I PI3K\/mTOR inhibitor as clinical candidate in oncology","volume":"60","author":"Beaufils","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106971_b0385","doi-asserted-by":"crossref","unstructured":"Rageot, D., Bohnacker, T., Melone, A., Langlois, J. B., Borsari, C., Hillmann, P., ... &Wymann, M. P. (2018). Discovery and preclinical characterization of 5-[4, 6-Bis ({3-oxa-8-azabicyclo [3.2. 1] octan-8-yl})-1, 3, 5-triazin-2-yl]-4-(difluoromethyl) pyridin-2-amine (PQR620), a highly potent and selective mTORC1\/2 inhibitor for cancer and neurological disorders.Journal of Medicinal Chemistry,61(22), 10084-10105. https:\/\/doi.org\/10.1021\/acs.jmedchem.8b01262.","DOI":"10.1021\/acs.jmedchem.8b01262"},{"issue":"13","key":"10.1016\/j.bioorg.2023.106971_b0390","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.1021\/acs.jmedchem.9b00525","article-title":"(S)-4-(Difluoromethyl)-5-(4-(3-methylmorpholino)-6-morpholino-1, 3, 5-triazin-2-yl) pyridin-2-amine (PQR530), a potent, orally bioavailable, and brain-penetrable dual inhibitor of class I PI3K and mTOR kinase","volume":"62","author":"Rageot","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106971_b0395","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.ejmech.2017.09.002","article-title":"Discovery of 1-(3-aryl-4-chlorophenyl)-3-(p-aryl) urea derivatives against breast cancer by inhibiting PI3K\/Akt\/mTOR and Hedgehog signalings","volume":"141","author":"Li","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"16","key":"10.1016\/j.bioorg.2023.106971_b0400","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1016\/j.bmcl.2017.06.060","article-title":"Design and synthesis of 4-morpholino-6-(1, 2, 3, 6-tetrahydropyridin-4-yl)-N-(3, 4, 5-trimethoxyphenyl)-1, 3, 5-triazin-2-amine analogues as tubulin polymerization inhibitors","volume":"27","author":"Narva","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2023.106971_b0405","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1016\/j.ejmech.2017.11.005","volume":"143","author":"\u017bo\u0142nowska","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2023.106971_b0410","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1021\/acs.jmedchem.7b01449","article-title":"Tozasertib analogues as inhibitors of necroptotic cell death","volume":"61","author":"Hofmans","year":"2018","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2023.106971_b0415","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.bmc.2019.02.050","article-title":"Synthesis and biological evaluation of solubilized sulfonamide analogues of the phosphatidylinositol 3-kinase inhibitor ZSTK474","volume":"27","author":"Giddens","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106971_b0420","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.molstruc.2018.11.082","article-title":"Synthesis, chemical and biological investigations of new Ru (III) and Se (IV) complexes containing 1, 3, 5-triazine chelating derivatives","volume":"1179","author":"Al-Khodir","year":"2019","journal-title":"J. Mol. Struct."},{"issue":"19","key":"10.1016\/j.bioorg.2023.106971_b0425","doi-asserted-by":"crossref","first-page":"8917","DOI":"10.1021\/acs.jmedchem.8b01147","article-title":"Design and synthesis of novel amino-triazine analogues as selective Bruton\u2019s tyrosine kinase inhibitors for treatment of rheumatoid arthritis","volume":"61","author":"Kawahata","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106971_b0430","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.ejmech.2018.07.048","article-title":"Novel ruthenium (II) triazine complex [Ru (bdpta)(tpy)] 2+ co-targeting drug resistant GRP78 and subcellular organelles in cancer stem cells","volume":"156","author":"Purushothaman","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106971_b0435","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ejmech.2018.03.066","article-title":"Phthalimide conjugations for the degradation of oncogenic PI3K","volume":"151","author":"Li","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106971_b0440","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1021\/acs.jmedchem.9b00622","article-title":"Discovery of novel dual poly (ADP-ribose) polymerase and phosphoinositide 3-kinase inhibitors as a promising strategy for cancer therapy","volume":"63","author":"Wang","year":"2019","journal-title":"J. Med. Chem."},{"issue":"13","key":"10.1016\/j.bioorg.2023.106971_b0445","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1016\/j.bmc.2019.05.022","article-title":"Development of novel macrocyclic small molecules that target CTG trinucleotide repeats","volume":"27","author":"Serrano","year":"2019","journal-title":"Bioorg. Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2023.106971_b0450","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.bmc.2019.03.001","article-title":"Discovery of new ureido benzenesulfonamides incorporating 1, 3, 5-triazine moieties as carbonic anhydrase I, II, IX and XII inhibitors","volume":"27","author":"Lolak","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106971_b0455","doi-asserted-by":"crossref","unstructured":"Teng, Y., Lu, X., Xiao, M., Li, Z., Zou, Y., Ren, S., ... & Xiang, H. (2020). Discovery of potent and highly selective covalent inhibitors of Bruton\u2019s tyrosine kinase bearing triazine scaffold.European Journal of Medicinal Chemistry,199, 112339.Teng, Y., Lu, X., Xiao, M., Li, Z., Zou, Y., Ren, S., ... & Xiang, H. (2020). Discovery of potent and highly selective covalent inhibitors of Bruton\u2019s tyrosine kinase bearing triazine scaffold.Eur. J. Med. Chem.,199, 112339.","DOI":"10.1016\/j.ejmech.2020.112339"},{"issue":"31","key":"10.1016\/j.bioorg.2023.106971_b0460","doi-asserted-by":"crossref","first-page":"13909","DOI":"10.1039\/D1NJ02419A","article-title":"Novel 1, 3, 5-triazine-based pyrazole derivatives as potential antitumor agents and EFGR kinase inhibitors: Synthesis, cytotoxicity, DNA binding, molecular docking and DFT studies","volume":"45","author":"Raghu","year":"2021","journal-title":"New J. Chem."},{"issue":"28","key":"10.1016\/j.bioorg.2023.106971_b0465","doi-asserted-by":"crossref","first-page":"24858","DOI":"10.1021\/acsomega.2c03079","article-title":"Synthesis and antiproliferative activity of a new series of mono-and bis (dimethylpyrazolyl)-s-triazine derivatives targeting EGFR\/PI3K\/AKT\/mTOR signaling cascades","volume":"7","author":"Shawish","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioorg.2023.106971_b0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106263","article-title":"Novel 6-amino-1, 3, 5-triazine derivatives as potent BTK inhibitors: Structure-activity relationship (SAR) analysis and preliminary mechanism investigation","volume":"130","author":"Xiao","year":"2023","journal-title":"Bioorg. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206823006326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206823006326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:48:39Z","timestamp":1758617319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206823006326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":94,"alternative-id":["S0045206823006326"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2023.106971","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthetic and pharmacological developments in the hybrid s-triazine moiety: A review","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2023.106971","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106971"}}